Aflibercept in Recurrent or Persistent CNV

Abroad (travel likely)Recruiting

Conditions

Age Related Macular Degeneration · Intravitreal Injections · Diabetic Macular Edema

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Medical University of Vienna, Vienna, Austria
Contact: Study coordinator (Reinhard Told, MD, PhD) · +43140400

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO

Neovascular Age-Related Macular Degeneration (NVAMD) · Branch Retinal Vein Occlusion (BRVO)

Abroad (travel likely)RecruitingPHASE2

Scottsdale, United States · Scottsdale, United States

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD

AMD · nAMD · Wet Age-related Macular Degeneration

Abroad (travel likely)RecruitingPHASE3

Phoenix, United States · Phoenix, United States

4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

Neovascular (Wet) Age-Related Macular Degeneration

Abroad (travel likely)RecruitingPHASE1, PHASE2

Phoenix, United States · Oxnard, United States

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Geographic Atrophy · Macular Degeneration

Abroad (travel likely)RecruitingPHASE2

Tucson, United States · Fullerton, United States